PL418295A1 - Granulated material that contains butyrate compound, method for obtaining it and applications - Google Patents

Granulated material that contains butyrate compound, method for obtaining it and applications

Info

Publication number
PL418295A1
PL418295A1 PL418295A PL41829516A PL418295A1 PL 418295 A1 PL418295 A1 PL 418295A1 PL 418295 A PL418295 A PL 418295A PL 41829516 A PL41829516 A PL 41829516A PL 418295 A1 PL418295 A1 PL 418295A1
Authority
PL
Poland
Prior art keywords
obtaining
applications
granulated material
butyrate compound
subject
Prior art date
Application number
PL418295A
Other languages
Polish (pl)
Other versions
PL233287B1 (en
Inventor
Michał Łuczyński
Original Assignee
Łuczyńska Katarzyna Chemprof Doradztwo Chemiczne Spółka Cywilna
Łuczyński Michał Chemprof Doradztwo Chemiczne Spółka Cywilna
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Łuczyńska Katarzyna Chemprof Doradztwo Chemiczne Spółka Cywilna, Łuczyński Michał Chemprof Doradztwo Chemiczne Spółka Cywilna filed Critical Łuczyńska Katarzyna Chemprof Doradztwo Chemiczne Spółka Cywilna
Priority to PL418295A priority Critical patent/PL233287B1/en
Publication of PL418295A1 publication Critical patent/PL418295A1/en
Publication of PL233287B1 publication Critical patent/PL233287B1/en

Links

Landscapes

  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Przedmiotem zgłoszenia jest granulat zawierający od 45 do 85% wag. związku maślanu, korzystnie maślanu sodu, w matrycy acyloglicerolowej, zawierającej acyloglicerole w określonej proporcji. Przedmiotem zgłoszenia jest także sposób wytwarzania i zastosowanie granulatu w zapobieganiu chorobom i/lub leczeniu chorób jelit o podłożu zapalnym lub jako żywności specjalnego przeznaczenia medycznego.The subject of the application is a granulate containing from 45 to 85 wt. butyrate compound, preferably sodium butyrate, in an acylglycerol matrix, containing acylglycerols in a certain proportion. The subject of the application is also a method for the production and use of granules in the prevention of and / or the treatment of inflammatory bowel diseases or as food for special medical purposes.

PL418295A 2016-08-11 2016-08-11 Granulated material that contains butyrate compound, method for obtaining it and applications PL233287B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PL418295A PL233287B1 (en) 2016-08-11 2016-08-11 Granulated material that contains butyrate compound, method for obtaining it and applications

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL418295A PL233287B1 (en) 2016-08-11 2016-08-11 Granulated material that contains butyrate compound, method for obtaining it and applications

Publications (2)

Publication Number Publication Date
PL418295A1 true PL418295A1 (en) 2018-02-12
PL233287B1 PL233287B1 (en) 2019-09-30

Family

ID=61148664

Family Applications (1)

Application Number Title Priority Date Filing Date
PL418295A PL233287B1 (en) 2016-08-11 2016-08-11 Granulated material that contains butyrate compound, method for obtaining it and applications

Country Status (1)

Country Link
PL (1) PL233287B1 (en)

Also Published As

Publication number Publication date
PL233287B1 (en) 2019-09-30

Similar Documents

Publication Publication Date Title
PH12018501226A1 (en) Methods for treating huntingtons disease
JOP20170105B1 (en) Amide-substituted pyridinyltriazole derivatives and uses thereof
WO2018134685A3 (en) Compounds
PH12017501669A1 (en) Alpha-cinnamide compounds and compositions as hdac8 inhibitors
MX2020003139A (en) Composition and method for aiding sleep.
MX355330B (en) CRYSTALLINE FORMS OF THERAPEUTIC COMPOUNDS and USES THEREOF.
PH12015502588A1 (en) 4`-fluoro-2`-methyl substituted nucleoside derivatives
MY190647A (en) Compounds effective in treating hepatotoxicity and fatty liver diseases and uses thereof
MY201921A (en) Agent for preventing or treating fat-associated diseases and/or inflammation
MX2023010501A (en) Dantrolene prodrugs and methods of their use.
PH12019550265A1 (en) Composition comprising mannose oligosaccharide and process for making same and use thereof
MX2021007260A (en) Jak1 pathway inhibitors for the treatment of gastrointestinal disease.
MX2016011358A (en) Liquid lactase compositions.
MY190687A (en) Antimicrobial compositions and related methods of use
MX2021013354A (en) Methods of treating and/or preventing actinic keratosis.
BR112017020968A2 (en) A water depurator and a water cleaning method
WO2018081183A3 (en) Maca compositions and methods of use
BR112017020971A2 (en) A water depurator and a water cleaning method
CL2018001017A1 (en) Conservation of water-soluble vitamins.
PL418295A1 (en) Granulated material that contains butyrate compound, method for obtaining it and applications
IL283902A (en) Co-crystal of ketoprofen, compositions comprising the same, process of producing the same, and uses thereof
MX2019004576A (en) Pharmaceutical compositions.
TW201613827A (en) Nitrifying bacterium inhibitor, and nitrifying bacterium inhibition method
JP2017014164A5 (en)
PH12020550444A1 (en) Use of fused heteroaromatic pyrrolidones for treatment and prevention of diseases in animals